lobbying_activities: 2637414

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2637414	88a4b57c-d2f7-40d0-998f-7eb3c22b59ae	Q2	BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	401104621	BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	2021	second_quarter	PHA	HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE		110000	0	0	2021-07-14T20:17:17.333000-04:00